Auto Summaries

Last updated: 2024 Oct 18

Total hit(s): 21574

S.No.
1	38787317	Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".	N/A	Hum Vaccin Immunother	2024 Dec 31	4.7	1
2	38709953	Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.	N/A	Hum Vaccin Immunother	2024 Dec 31	4.7	1
3	38626299	Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.	N/A	Hum Vaccin Immunother	2024 Dec 31	4.7	1
4	39348537	US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.	N/A	Proc Natl Acad Sci U S A	2024 Oct 8	9.35	1
5	39348533	Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.	N/A	Proc Natl Acad Sci U S A	2024 Oct 8	9.35	1
6	39396886	Corrigendum to "A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases" [Vaccine 42 (12) (2024) 3039-3048].	N/A	Vaccine	2024 Oct 12	3.31	1
7	39396884	Corrigendum to "The Efficient and Practical virus Identification System with ENhanced Sensitivity for Solids (EPISENS-S): A rapid and cost-effective SARS-CoV-2 RNA detection method for routine wastewater surveillance" [Sci. Total Environ. 843 (2022) 157101 (15 October)].	N/A	Sci Total Environ	2024 Oct 12	5.9	1
8	39394035	Corrigendum to 'COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry' [Journal of Thrombosis and Haemostasis Volume 22, Issue 1, January 2024, Pages 61-75].	N/A	J Thromb Haemost	2024 Oct 10	4.45	1
9	39352650	Response to the Letter to the Editor Regarding "Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study".	N/A	Infect Dis Ther	2024 Oct 1	3.95	1
10	39366391	A novel SARS-CoV-2 recombinant transmitted from a patient with an acute co-infection.	N/A	Lancet Microbe	2024 Oct 1	- n/a -	1
11	39206843	The death rate for melanoma remained unchanged in the USA during the coronavirus disease 2019 pandemic.	N/A	Melanoma Res	2024 Oct 1		1
12	39284643	Impact of the COVID-19 vaccine mandate on vaccine uptake and infection risk in a large cohort of Canadian health care workers: Correspondence.	N/A	Am J Infect Control	2024 Oct	2.03	1
13	39284644	Response to letter to the editor: Did the health care vaccine mandate work? An evaluation of the impact of the COVID-19 vaccine mandate on vaccine uptake and infection risk in a large cohort of Canadian health care workers.	N/A	Am J Infect Control	2024 Oct	2.03	1
14	38762364	Psychiatric consultations at an Academic Medical Center during alpha strain of the COVID-19 pandemic: A comparison of COVID-19 positive and COVID-19 negative patients.	N/A	Gen Hosp Psychiatry	2024 Sep-Oct	3.4	1
15	39251252	Covid:19: NHS staff still struggling with "traumatic memories" of pandemic, report finds.	N/A	BMJ	2024 Sep 9	30.22	1
16	39229889	Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient.	N/A	Scand J Rheumatol	2024 Sep 4		1
17	39342358	Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults.	N/A	AIDS Res Ther	2024 Sep 28	2.5	1
18	39341723	Corrigendum to "Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received" [Vaccine 42 (22) (2024) 126025].	N/A	Vaccine	2024 Sep 27	3.31	1
19	39329285	Epidemiological survey and risk factors for COVID-19 infection among students following downgraded management: A cross-sectional study.	N/A	Chin Med J (Engl)	2024 Sep 27	1.053	1
20	39290155	Will mortality rates in the next viral pandemic be affected by the COVID-19 experience?	N/A	J Infect Dis	2024 Sep 18	4.73	1
21	39250343	COVID-19 update: New Pfizer and Moderna vaccine formulations for 2024-2025.	N/A	Med Lett Drugs Ther	2024 Sep 16	0.8	1
22	38761805	Immune evasiveness of SARS-CoV-2 variants and vaccine selection.	N/A	Lancet Infect Dis	2024 Sep	21.77	1
23	39285619	Evolving dynamics of COVID-19 vaccine hesitancy in China: Perspectives and suggestions from Taiwan.	N/A	J Med Virol	2024 Sep	2.07	1
24	39048419	Response to "The experience of pregnant women and their families who were infected with covid-19 before vaccination: Comment".	N/A	Midwifery	2024 Sep	4.3	1
25	39269353	[Molnupiravir reduces symptoms duration but does not decrease hospitalizations or deaths in vaccinated adults with Covid-19.].	N/A	Recenti Prog Med	2024 Sep	0.7	1